Nicholas Schiefer on Twitter: "@voretaq7 "Worth it" is a value judgment: we're trading off potential risks and potential benefits. Personally, I think that the FDA's value judgment here is wrong. I would personally take a Delta booster with much less additional testing, and I am sad that I legally cannot." / Twitter

This Tweet is from a suspended account. Learn more

Nicholas Schiefer

@nschiefer

Aug 11, 2021

Replying to

@voretaq7

Wait, the FDA's enforcement of a particular standard for drug licensing is *definitely* the bottleneck here. I think you're saying that the FDA's bureaucracy is doing a good job of implementing the regulatory standards we've collectively adopted. Does that sound right?

1

Replying to

and

Put another way: if we had no drug regulatory regime at all, or one based on much looser standards of evidence, I could likely get a Delta booster shot today. So in that sense, the existence of the FDA is a bottleneck, right? That bottleneck might be worth it, of course.

1

This Tweet is from a suspended account. Learn more

Replying to

Right, sure. My takeaway is the (perhaps more precise?) statement that the FDA is a *worthwhile* bottleneck, from your perspective. Also that the FDA is pretty good at implementing the regulatory standard that it is trying to implement, at least in the case of COVID vaccines.

1

Replying to

and

"Worth it" is a value judgment: we're trading off potential risks and potential benefits. Personally, I think that the FDA's value judgment here is wrong. I would personally take a Delta booster with much less additional testing, and I am sad that I legally cannot.

9:54 PM · Aug 11, 2021Twitter Web App

Conversation